Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

NCT01949129 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1800

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukaemia

Interventions

DRUG: VP16
RADIATION: TBI
DRUG: Thiotepa
DRUG: Treosulfan
DRUG: Fludarabine
DRUG: Busulfan
DRUG: ATG Thymoglobulin
DRUG: Cyclophosphamide
DRUG: Grafalon

Sponsor

St. Anna Kinderkrebsforschung

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]